↓ Skip to main content

Dove Medical Press

Organic mononitrites of 1,2-propanediol act as an effective NO-releasing vasodilator in pulmonary hypertension and exhibit no cross-tolerance with nitroglycerin in anesthetized pigs

Overview of attention for article published in Drug Design, Development and Therapy, March 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
1 X user
patent
2 patents

Readers on

mendeley
14 Mendeley
Title
Organic mononitrites of 1,2-propanediol act as an effective NO-releasing vasodilator in pulmonary hypertension and exhibit no cross-tolerance with nitroglycerin in anesthetized pigs
Published in
Drug Design, Development and Therapy, March 2018
DOI 10.2147/dddt.s149727
Pubmed ID
Authors

Kristofer F Nilsson, Waldemar Goździk, Claes Frostell, Stanisław Zieliński, Marzena Zielińska, Kornel Ratajczak, Piotr Skrzypczak, Sylwia Rodziewicz, Johanna Albert, Lars E Gustafsson

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 29%
Student > Bachelor 3 21%
Professor > Associate Professor 2 14%
Student > Master 1 7%
Student > Ph. D. Student 1 7%
Other 0 0%
Unknown 3 21%
Readers by discipline Count As %
Medicine and Dentistry 4 29%
Pharmacology, Toxicology and Pharmaceutical Science 2 14%
Environmental Science 1 7%
Biochemistry, Genetics and Molecular Biology 1 7%
Chemistry 1 7%
Other 0 0%
Unknown 5 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2020.
All research outputs
#7,388,045
of 25,461,852 outputs
Outputs from Drug Design, Development and Therapy
#487
of 2,272 outputs
Outputs of similar age
#121,661
of 345,064 outputs
Outputs of similar age from Drug Design, Development and Therapy
#12
of 48 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,272 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,064 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.